400 In the last decades, researchers have showed that IR is an early metabolic alteration in CKD, because IR plays a primary role in metabolic syndromes characterized by abdominal obesity, high fasting glucose levels, hypertriglyceridemia, depressed serum HDL-C, and high blood pressure, that are commonly observed in CKD patients
Finding the right provider Combining HRT and GLP-1 medications requires a provider who understands both endocrinology and metabolic medicine
Therefore, if you hear someone talking about an injection for weight loss and diabetes, they are referring to GLP-1 receptor agonists like semaglutide or tirzepatide, not insulin
Clinically Proven Ingredients Science-backed medications and personalized treatments formulated with proven, clinically tested ingredients that meet the highest standards of safety and effectiveness